SCHEMBL9360294

SCHEMBL9360294

CCc1[nH]c(=O)oc1-c1ccc2ncccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.49
POLB P06746 1/20 0.49
RAB9A P51151 1/20 0.49
DYRK1A Q13627 1/20 0.45
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
UTRN P46939 2/20 0.42
METAP2 P50579 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
MCL1 Q07820 1/20 0.40
DAO P14920 1/20 0.39
TGFBR1 P36897 1/20 0.39
TGFBR2 P37173 1/20 0.39
ADORA1 P30542 1/20 0.39
MAT2A P31153 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9361685 0.74 PDE10A (0.44) UTRNKDM5B
SCHEMBL10771601 0.70 PDE4A (0.53) CYP1A2CYP3A4CYP2C19ALDH1A1KDM4E
SCHEMBL30743 0.69 NPC1 (1.00) NPC1POLBRAB9ADYRK1AMAPT
SCHEMBL29757180 0.69 NPC1 (1.00) NPC1POLBRAB9ADYRK1AMAPT
SCHEMBL20371603 0.67 RAB9A (0.61) NPC1POLBRAB9ADYRK1AMAPT
SCHEMBL14741278 0.67 MCL1 (0.53) NPC1POLBRAB9AMAPTCYP1A2
SCHEMBL1150800 0.66 NPC1 (0.54) NPC1POLBRAB9ADYRK1AMAPT
SCHEMBL2502604 0.66 TOP2A (0.49) DYRK1ACYP1A2KDM5B
SCHEMBL11833 0.65 ALDH1A1 (0.58) NPC1POLBRAB9ADYRK1AMAPT
SCHEMBL9710552 0.65 ADH5 (0.52) CYP1A2CYP3A4CYP2C19TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365863-B1 Novel quinolyloxazole-2-ones useful as proteinkinase C inhibitors MERRELL DOW PHARMA (US) 1994-08-17 EP disclosed
EP-0428105-B1 Use of quinolyl- and isoquinolyloxazole-2-ones for the production of a medicament for the prevention of glycoprotein enveloped virus infectivity MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
EP-0428107-B1 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
US-4999431-A Reacting A Bromoquinoline Compound With Butyllithium And An N-Methyl-N-Methoxyalkanamide; Intermediates for Quinolyloxazole-2-ones MERRELL DOW PHARMACEUTICALS (US) 1991-03-12 US disclosed
US-4990519-A Antiasthma, hypotensive agents, bronchodilator agents MERRELL DOW PHARMACEUTICALS (US) 1991-02-05 US disclosed
US-4886811-A HYPOTENSIVE AGENTS AND VASODILATORS MERRELL DOW PHARMACEUTICALS (US) 1989-12-12 US disclosed